Derivative and Q-analysis spectrophotometric methods for estimation of hydrochlorothiazide and olmesartan medoxomil in tablets

Indian Journal of Pharmaceutical Sciences

Volumn 71, Issue 5, 2009, Pages 505-508

  Bhusari, K P ^a   Khedekar, P B ^a   Dhole, Seema ^a   Banode, V S ^b  

^a Nagar Yuwak Shikshan Sanstha   (India)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Derivative and Q analysis spectrophotometric methods; Hydrochlorothiazide; Olmesartan medoxomil

Indexed keywords

HYDROCHLOROTHIAZIDE; OLMESARTAN;

ACCURACY; ANALYTIC METHOD; ARTICLE; DRUG ABSORPTION; QUALITY CONTROL; SPECTROPHOTOMETRY; TABLET;

EID: 72749103942     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.58176     Document Type: Article

References (25)

1. Indian Pharmacopoeia, Vol.1, Government of India, Ministry of wealth and family welfare. New Delhi: The Controller of Publication; 1996. p. 370-372
2. British Pharmacopoeia, Vol.1, Department of Health and Social Services for Northern Ireland, London: Stationery Publications; 1998. p. 1727-1728
3. The United State Pharmacopoeia 24 and National Formulary 19, Asian ed. Rockville MD: United State Pharmacopoeial Convention Inc; 2000. p. 820-821
4. Budavari S. The merck index: An encyclopedia of chemicals, drugs and biologicals, 13th ed. Merck Research Laboratories, Whitehouse Station, NJ: Merck and Co. Inc.; 2001. p. 854.
5. Sweetman SC. Martindale: The complete drug reference. 33rd ed. London: The Pharmaceutical Press; 2002. p. 907.
6. Pawar S, Phadke M, Jadhav V. Simultaneous spectrophotometric estimation of Lisinopril and Hydrochlorothiazide tablet using a stability indicating RP-HPLC method. Indian Drugs 2006;43:429-432
7. Suhagia BN, Shah RR, Pate DM. Development of RP-HPLC method for Losartan potassium and Hydrochlorothiazide. Indian J Pharm Sci 2005;67:37-42.
8. Jain SK, Jain D, Tiwari M, Chaturvedi SC. Simultaneous spectrophotometric estimation of Propanolol and Hydrochlorothiazide in formulation. Indian J Pharm Sci 2002;64:267-276
9. Prasad CVN, Parihar C, Sunil K, Parimoo P. Simultaneous determination of amiloride HCl, hydrochlorothiazide and atenolol in combined formulations by derivative spectroscopy. J Pharm Biomed Anal 1998;17:877-884
10. Hillaert S, Grauwe KD, Bossche WD. Simultaneous determination of hydrochlorothiazide and several inhibitors of angiotensin-converting enzyme by capillary electrophoresis. J Chromatogr A 2001;924:439-449
11. Gindy A, Ashour A, Fattah LA, Shabana MM. Application of LC and HPTLC-densitometry for simultaneous determination of benazepril hydrochloride and hydrochlorothiazide. J Pharm Biomed Anal 2001;25:171-179
12. Saglik S, Sagirli O, Atmaca S, Erosy L. Simultaneous determination of fosinopril and hydrochlorothiazide in tablets derivative spectrophotometric and high-performance liquid chromatographic method. Anal Chim Acta 2001;427:253-257
13. Erk N. Analysis of binary mixtures of losartan potassium and hydrochlorothiazide by using high-performance liquid chromatography, ratio derivative and compensation technique. J Pharm Biomed Anal 2001;24:603-611
14. Dinc E, Baleanu D. Spectrophotometric quantitative determination of cilazapril and hydrochlorothiazide in tablets by chemometric method. J Pharm Biomed Anal 2002;30:715-723
15. Takubo T, Okada H, Ishii M, Hara K, Ishii Y. Sensitive and selective liquid chromatography-electrospray ionization tandem mass spectrometry analysis of hydrochlorothiazide in rat plasma. J Chromatogr B 2004;806:199-203.
16. Razak OA. Electrochemical study of hydrochlorothiazide and its determination in urine and tablets. J Pharm Biomed Anal 2004;34: 433-440
17. Lusina M, Cindric T, Tomaic J, Peko M, Pozaic L, Musulin N. Stability study of losartan/hydrochlorothiazide tablets. Int J Pharm 2005;291: 127-137
18. Tripathi KD. Essentials of medical pharmacology. 5th ed. New Delhi: Jaypee Brothers, Medical Publishers; 2005. p. 528-532
19. Budavari S. The Merck Index: An encyclopedia of chemicals, drugs and biologicals, 13th ed. Merck research laboratories, Whitehouse Station, NJ: Merck and Co. Inc.; 2001. p. 1223-1224
20. Puchler K, Laeis P, Stumpe KO. A comparison of the efficacy and safety of the oral angiotensin II antagonist Olmesartan medoxomil with those of atenolol inpatients with moderate to severe hypertension under continuous treatment with hydrochlorothiazide. J Pharm Biomed Anal 2001;19:153-159
21. Krentz R, Bolbrinker J, Huber M. Pharmacokinetic of Olmesartan medoxomil plus Hydrochlorothiazide combination in healthy subjects. Clin Drug Invest 2006;26: 29-34. (Pubitemid 43098406)
22. Celebier M, Altinoz S. Development of a CZE method for the determination of Olmesartan medoxomil in tablets. Chromatographia 2007;66:929-933 (Pubitemid 350211964)
23. Shah NJ, Suhagia BN, Shah RR, Patel NM. Development and validation of a simultaneous HPTLC method for the estimation of olmesartan medoxomil and hydrochlorothiazide in tablet dosage form. J Pharm Sci 2007;69:834-836
24. ICH guidelines Q2B validation of analytical procedures: Methodology International Conference on Harmonization, Geneva, March 1996.
25. Beckett AH, Stanlake JB. Practical Pharmaceutical Chemistry. 4th ed. Part 2, New Delhi: CBS Publishers and Distributors; 1997. p. 282-299